Schnabel A, Kindermann W, Salas-Fraire O, Cassens J, Steinkraus V
Int J Sports Med. 1983 Nov;4(4):278-81. doi: 10.1055/s-2008-1026050.
Fourteen male physical education students performed a single bout of running until exhaustion on the treadmill at 22 km/h and 7.5% slope. They received single oral doses of 100 mg bupranolol (nonselective beta-blockade), 100 mg metoprolol (beta-1-selective blockade), and placebo 60-90 min before running. Arterialized capillary blood was sampled repeatedly until 30 min after exercise for assessment of lactate and glucose. Adrenaline and noradrenaline were determined in venous plasma before and immediately after exercise. Running time until exhaustion was 49.3 +/- 2.3 s in the control experiment, 44.5 +/- 2.0 s with metoprolol, and 42.7 +/- 2.0 s with bupranolol. The reductions under beta-blockade were statistically significant. With both beta-blockers the increases of the lactate and glucose blood levels were significantly reduced, the levels being almost identical with metoprolol and bupranolol. The post-exercise levels of adrenaline and noradrenaline did not differ significantly between the control, metoprolol, and bupranolol experiments. It is concluded that determination of the lactate and glucose levels in blood did not allow assessment of the mechanism by which beta-blockade impairs the capacity for supramaximal exercise. Besides reduced anaerobic energy release due to inhibition of glycogenolysis, other beta-blocker effects are considered.
14名男性体育专业学生在跑步机上以22公里/小时的速度和7.5%的坡度进行单次跑步直至力竭。他们在跑步前60 - 90分钟分别口服100毫克布普洛尔(非选择性β受体阻滞剂)、100毫克美托洛尔(β1选择性阻滞剂)和安慰剂。在运动后30分钟内反复采集动脉化毛细血管血样以评估乳酸和葡萄糖水平。运动前和运动后即刻测定静脉血浆中的肾上腺素和去甲肾上腺素。在对照实验中,直至力竭的跑步时间为49.3±2.3秒,服用美托洛尔后为44.5±2.0秒,服用布普洛尔后为42.7±2.0秒。β受体阻滞剂作用下跑步时间的减少具有统计学意义。使用两种β受体阻滞剂时,血液中乳酸和葡萄糖水平的升高均显著降低,美托洛尔和布普洛尔作用下的水平几乎相同。在对照、美托洛尔和布普洛尔实验中,运动后肾上腺素和去甲肾上腺素水平无显著差异。结论是,测定血液中的乳酸和葡萄糖水平无法评估β受体阻滞剂损害超最大运动能力的机制。除了由于糖原分解受抑制导致无氧能量释放减少外,还考虑了其他β受体阻滞剂的作用。